Companies: 10,795·Total market cap: $144.5T
Virax Biolabs Group Limited

Virax Biolabs Group Limited

VRAXNASDAQHealthcare● Active
$0.21
$-0.00(-1.74%)
Market Cap$906600
P/E Ratio—
52W High$1.14
52W Low$0.1
ForecastMarket CapPE Ratio

Virax Biolabs Group Limited（VRAX）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

vrax · 股价预测 · 1 位分析师（近3月）· FMP · 更新于 2026年6月9日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

SellBuy

Buy

1 位分析师

共识

评级分布

Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
合计: 1 · 买入占比: 100.0%

12 个月目标价

High

$1.00

Consensus

$1.00

+378.9% upside

Low

$1.00

Median: $1 · Last Close: $0.21

Virax Biolabs Group Limited（VRAX）的分析师共识为 Buy，基于过去 3 个月内 1 位华尔街分析师的评级。VRAX 的 12 个月平均目标价为 $1.00，相对当前价 $0.21 代表 +378.9% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

分析师目标价覆盖不足，无法为该股票生成预测图表。

短期股价预测

算法生成 · 每日更新

DatePredicted PriceChange
2026-06-10$0.21↑ 0.05%

1-day model range: $0.2–$0.21. Peak: $0.21 (+0.05%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

NEUTRAL

Based on 14 technical indicators

0%71%29%
0Buy
10Neutral
4Sell
RSI (14)46.2Neutral
MACDNEUTRAL

Refreshes daily from EOD close

Moving Averages · VRAX · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$0.22SELL
MA 10$0.21SELL
MA 20$0.00NEUTRAL
MA 50$0.00NEUTRAL
MA 100$0.00NEUTRAL
MA 200$0.00NEUTRAL
Current $VRAX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$0.21SELL
EMA 10$0.23SELL
EMA 20$0.00NEUTRAL
EMA 50$0.00NEUTRAL
EMA 100$0.00NEUTRAL
EMA 200$0.00NEUTRAL
Current $VRAX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

最新分析师评级与调整

Filter:
HC Wainwright & Co.2026-01-09
Maintains
Buy→Buy

Wall Street analysts have recently issued updated ratings on Virax Biolabs Group Limited (VRAX) stock. Of the recent 1 rating actions, 0 were upgrades and 0 were downgrades. 1 analysts currently cover VRAX.

分析师推荐趋势

Buy ratings1 → 1
Hold ratings0 → 0
Sell ratings0 → 0

VRAX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$0M

↑ 700.0% YoY

Revenue Next Year

$1M

↑ 600.0% YoY

EPS This Year

$-3.70

EPS Next Year

$-1.90

↓ 48.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast VRAX EPS of $-3.70 for the current fiscal year, based on estimates from 1 analysts. The VRAX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

VRAX 股价预测由两类独立数据源支撑：来自 1 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VRAX 的共识目标价为 $1.00（+378.9% 上行空间），分析师共识为 Buy。

VRAX 的短期预测（明日）为 $0.21（+0.05%）。

Virax Biolabs Group Limited 在 NASDAQ 上市，代码 VRAX。VRAX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

相关页面

盈利营收市盈率财务报表市值内幕交易股息价格历史

常见问题

VRAX 预测 · 8 个问题

根据 1 位华尔街分析师，VRAX 的 12 个月平均目标价为 $1.00，最高 $1.00、最低 $1.00。若有图表，中位目标价可在上方查看。相对当前价 $0.21，隐含约 +378.9% 的上行空间。

VRAX 目标价VRAX 分析师目标价VRAX 12个月目标价目标价 VRAX

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.